Journal of Experimental and Clinical Toxicology

Journal of Experimental and Clinical Toxicology

Journal of Experimental and Clinical Toxicology – Aim And Scope

Open Access & Peer-Reviewed

Submit Manuscript

Aims & Scope

Journal of Experimental and Clinical Toxicology (JECT) publishes mechanistic research on toxic substance interactions with biological systems, emphasizing dose-response relationships, exposure pathways, and molecular toxicity mechanisms across experimental and translational models.
Toxicity Mechanisms Exposure Science Dose-Response Biomarker Discovery Risk Assessment

Core Research Domains

Molecular & Cellular Toxicology

  • Toxicodynamic mechanisms at molecular level
  • Cellular signaling pathway disruption
  • Genotoxicity and DNA damage responses
  • Cytotoxicity mechanisms and cell death pathways
  • Oxidative stress and mitochondrial dysfunction
  • Receptor-mediated toxicity
Typical Fit: Investigation of MAPK pathway activation following heavy metal exposure in hepatocytes, with dose-response characterization and biomarker identification.

Toxicokinetics & Metabolism

  • Absorption, distribution, metabolism, excretion (ADME) of toxicants
  • Xenobiotic metabolism and biotransformation
  • Phase I and Phase II metabolic pathways
  • Toxicant-drug interactions
  • Bioaccumulation and biomagnification studies
  • Pharmacokinetic modeling of toxic substances
Typical Fit: Characterization of cytochrome P450-mediated metabolism of environmental pollutants with identification of toxic metabolites and elimination kinetics.

Environmental & Occupational Toxicology

  • Industrial pollutant exposure assessment
  • Pesticide toxicity mechanisms
  • Air pollutant biological effects
  • Water contaminant toxicology
  • Occupational hazard characterization
  • Persistent organic pollutant (POP) effects
Typical Fit: Mechanistic study of organophosphate pesticide-induced neurotoxicity in occupational exposure models, including acetylcholinesterase inhibition kinetics.

Organ-Specific Toxicology

  • Hepatotoxicity mechanisms and biomarkers
  • Nephrotoxicity and renal injury pathways
  • Neurotoxicity and neurodegeneration
  • Cardiotoxicity mechanisms
  • Pulmonary toxicity and respiratory effects
  • Reproductive and developmental toxicity
Typical Fit: Dose-dependent hepatotoxicity assessment of industrial solvents using in vitro and in vivo models, with mechanistic pathway analysis and predictive biomarker validation.

Secondary Focus Areas

Specialized Toxicology Fields

  • Nanotoxicology and nanomaterial safety
  • Immunotoxicology and immune dysfunction
  • Behavioral toxicology and neurobehavioral effects
  • Ophthalmological toxicity mechanisms
  • Ototoxicity and auditory system damage

Methodological Innovations

  • In vitro toxicity testing platforms
  • High-throughput screening methods
  • Organ-on-chip toxicology models
  • 3D cell culture toxicity assessment
  • Alternative to animal testing (NAMs)

Computational Toxicology

  • QSAR modeling for toxicity prediction
  • Systems toxicology approaches
  • Toxicogenomics and transcriptomics
  • AI/machine learning in toxicity assessment
  • Adverse outcome pathway (AOP) development

Risk Assessment & Regulatory Science

  • Quantitative risk assessment methodologies
  • Benchmark dose modeling
  • Safety threshold determination
  • Regulatory toxicology data generation
  • Hazard characterization studies

Emerging Research Areas

Frontier Topics Selective Review

Microplastic toxicity mechanisms
PFAS (forever chemicals) biological effects
Climate change and toxicant interactions
Endocrine disrupting chemical mechanisms
Epigenetic toxicology
Gut microbiome-toxicant interactions
Note: Manuscripts in emerging areas undergo additional editorial review to ensure mechanistic depth and alignment with journal scope. Purely descriptive or observational studies without mechanistic investigation may be declined.
📄

Article Types & Editorial Priorities

Priority 1 Fast-Track Review (24 days)
Original Research Articles
Review Articles & Literature Reviews
Mini-Reviews
Short Communications & Rapid Communications
Priority 2 Standard Review (24 days)
Clinical Case Reports
Clinical Trials
Letters
Editorials
Commentaries
Theses
Opinions
Book Reviews
Perspectives
Conference Proceedings
Rarely Considered By invitation or exceptional merit only
Case Reports
Opinion Pieces
Commentaries

Editorial Standards & Requirements

Reporting Guidelines

  • ARRIVE 2.0 for animal studies
  • STROBE for observational studies
  • PRISMA for systematic reviews
  • MIAME for microarray data
  • Good Laboratory Practice (GLP) compliance

Data & Reproducibility

  • Raw data deposition in public repositories
  • Statistical analysis transparency
  • Methodological detail for reproducibility
  • Dose-response data reporting
  • Negative results encouraged

Ethics & Compliance

  • IACUC approval for animal studies
  • IRB approval for human subjects
  • Conflict of interest disclosure
  • Funding source transparency
  • Industry collaboration disclosure

Preprint & Prior Publication

  • Preprints allowed (bioRxiv, medRxiv)
  • Conference abstracts permitted
  • Thesis chapters acceptable with disclosure
  • No duplicate publication
  • Prior datasets may be reanalyzed

Editorial Decision Metrics

24 days First Decision
53% Acceptance Rate
3 days To Publication
45 days Submission to Publication